GleamWall
中文EN

LH LABCORP HOLDINGS INC.

Services-Medical Laboratories · NYSE · SEC CIK 920148 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY6.0%
TTM net income YoY17.4%
TTM EPS YoY19.7%
Revenue 3-yr CAGR6.6%
Net income 3-yr CAGR14.9%

Margins

Gross margin29.0%
Operating margin10.3%
Net margin6.9%
FCF margin8.8%
EBITDA margin15.1%

Returns

ROE11.4%
ROA5.4%
ROIC (approx.)8.6%
Asset turnover0.78x

Leverage & solvency

Liabilities / assets53.2%
Debt / equity0.66x
Current ratio1.41x
Interest coverage6.52x

Cash quality & payout

Operating cash flow / net income1.81x
Accruals ratio-4.4%
Payout ratio23.6%
Capex / revenue3.6%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$3.81B$3.73B$3.54B$3.52B$3.56B$3.53B$3.35B$3.33B
Cost of revenue$2.70B$2.62B$2.52B$2.52B$2.54B$2.48B$2.40B$2.43B
Gross profit$1.11B$1.11B$1.01B$993.20M$1.03B$1.05B$948.00M$896.30M
SG&A expense$611.40M$577.20M$551.00M$538.60M$553.10M$579.30M$546.00M$595.20M
Operating income$402.10M$451.60M$380.80M$267.60M$396.60M$394.50M$326.00M$216.50M
Interest expense$59.10M$61.10M$55.10M$55.00M$56.00M$57.10M$56.00M$63.40M
Income tax$64.90M$87.30M$41.70M$25.70M$75.50M$66.40M$62.20M$40.20M
Net income$262.80M$298.70M$277.80M$164.70M$261.10M$237.90M$212.80M$143.40M
EBITDA$585.10M$630.60M$554.10M$440.60M$567.60M$564.80M$492.80M$387.10M
EPS (basic)3.243.663.37—3.142.852.54—
EPS (diluted)3.223.643.35—3.122.842.52—
Dividends declared per share0.720.720.720.720.720.720.720.72
Weighted avg. shares (diluted)81.60M82.00M82.90M—83.70M83.90M84.30M—
Balance sheet
Cash & equivalents$261.80M$141.80M$981.10M$532.30M$598.10M$647.30M$369.40M$1.52B
Receivables$2.41B$2.34B$2.29B$2.10B$2.11B$2.12B$2.12B$1.94B
Inventory$538.40M$562.20M$497.70M$534.70M$521.50M$508.10M$488.30M$493.20M
Current assets$3.97B$3.81B$4.56B$4.02B$4.08B$4.09B$3.79B$4.81B
PP&E, net$3.14B$3.10B$3.07B$3.08B$3.11B$3.13B$3.09B$3.05B
Goodwill$7.18B$7.03B$6.96B$6.79B$6.68B$6.55B$6.42B$6.37B
Intangibles$3.72B$3.68B$3.64B$3.60B$3.57B$3.49B$3.49B$3.49B
Total assets$18.92B$18.53B$19.09B$18.39B$18.26B$18.06B$17.60B$18.38B
Current liabilities$2.82B$2.12B$2.64B$2.82B$2.63B$2.72B$2.06B$3.33B
Short-term debt$601.20M$900,000$500.40M$500.10M———$1.00B
Long-term debt$5.25B$5.86B$5.83B$5.08B$5.08B$5.08B$5.57B$5.33B
Total debt$5.85B$5.86B$6.33B$5.58B$5.08B$5.08B$5.57B$6.33B
Total liabilities$10.06B$9.91B$10.34B$9.76B$9.55B$9.57B$9.28B$10.31B
Shareholders' equity$8.85B$8.61B$8.73B$8.62B$8.70B$8.47B$8.31B$8.05B
Net debt$5.59B$5.72B$5.35B$5.05B$4.48B$4.43B$5.20B$4.81B
Shares outstanding81.20M80.90M82.30M82.20M83.00M82.90M83.80M83.40M
Cash flow statement
Operating cash flow$563.80M$445.50M$191.50M$614.20M$387.20M$620.60M$18.50M$777.20M
Capital expenditure$151.60M$131.60M$121.00M$123.90M$106.70M$77.90M$126.00M$112.10M
Free cash flow$412.20M$313.90M$70.50M$490.30M$280.50M$542.70M-$107.50M$665.10M
Investing cash flow-$433.70M-$366.20M-$322.10M-$389.90M-$374.00M-$94.10M-$336.00M-$209.60M
Financing cash flow-$10.00M-$919.90M$580.50M-$290.40M-$59.50M-$267.40M-$839.70M-$546.70M
Depreciation & amortization$183.00M$179.00M$173.30M$173.00M$171.00M$170.30M$166.80M$170.60M
Stock-based compensation$30.80M$34.90M$31.70M$29.70M$29.20M$34.10M$32.80M$27.30M
Dividends paid$58.20M$58.70M$61.20M$59.30M$59.90M$59.90M$61.60M$60.10M
Share buybacks$0$353.80M$98.00M$225.00M$25.00M$200.00M$0$75.10M

Free plan shows the latest 8 periods; Pro shows all 74 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.